精细调整组合的脂质纳米颗粒显示强化结肠向作为mRNA治疗平台
Riccardo Rampado1,2,3,4, Gonna Somu Naidu1,2,3,4, Olga Karpov1,2,3,4
1Laboratory of Precision Nanomedicine, Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Tel Aviv-Yafo, 69978, Israel.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|November 25, 2024
概括
修改后的脂质纳米颗粒 (LNP) 增加了脂,显示肝脏/脏积累减少,并准炎症结肠. 这种RNA输送系统有效地治疗小鼠的炎症性肠病.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 药物运输 药物运输 药物运输
背景情况:
- 脂质纳米颗粒 (LNP) 对于RNA传递至关重要,目前正在进行研究以提高其耐受性和向性.
- 目前的LNP配方经常使用已确定的脂质比例,限制了基于成分的生物分布的探索.
- 研究LNP组成为优化粒子设计和传递策略提供了新的途径.
研究的目的:
- 探索一种具有较高脂含量的新型LNP配方 (30-n-LNP),用于炎症性肠病中的mRNA输送.
- 与基准LNP (b-LNP) 相比,评估30-n-LNP的生物分布,耐受性和治疗疗效.
主要方法:
- 配制新的LNP (n-LNP) 含有30%的二甲基酸胆 (DSPC).
- 在硫酸 (DSS) 诱导的大肠炎小鼠模型中静脉注射LNP.
- 对LNP生物分布的评估,包括针对炎症结肠和消除肝脏和脏的向.
- 使用互白素-10 (IL-10) mRNA作为货物的治疗效果的评估.
主要成果:
- 在静脉注射后,30-n-LNP被很好地容忍.
- n-LNP在炎症结肠中表现出偏好的积累,同时减少了肝脏和脏的吸收.
- 载有IL-10mRNA的n-LNP显著降低了大肠炎携带小鼠的病理负担.
结论:
- 增加LNP中的脂含量可以调节系统生物分布,增强结肠向.
- 这种修改后的LNP成分为炎症性肠道疾病中向mRNA输送提供了一个有希望的策略.
- 对LNP成分的进一步研究可以为各种病理解锁新的治疗应用.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


